Literature DB >> 22971541

Repeated orexin 1 receptor antagonism effects on cocaine seeking in rats.

Luyi Zhou1, Rachel J Smith, Phong H Do, Gary Aston-Jones, Ronald E See.   

Abstract

The orexin/hypocretin system has been implicated in multiple phases of drug addiction. Acute orexin receptor blockade with the orexin-1 receptor (OX1R) antagonist, SB-334867, has been found to reduce cocaine seeking after cocaine self-administration. As repeated drug dosing can have differential effects and is more clinically relevant than acute dosing, in the current study we examined the effects of repeated SB-334867 on cocaine self-administration, extinction, and reinstatement to cocaine seeking in Sprague-Dawley rats. We found that repeated SB-334867 (10 mg/kg/day) had no effect on established cocaine self-administration. Repeated SB-334867 (both 10 and 20 mg/kg) attenuated cocaine seeking during extinction; however, this effect was only observed when animals had no prior experience with SB-334867 and when SB-334867 was administered prior to, but not after, daily extinction sessions. Notably, daily treatment with SB-334867 (10 mg/kg) during extinction increased subsequent cue-induced reinstatement, whereas repeated SB-334867 (20 mg/kg) administration during extinction enabled acute SB-334867 to reduce cue-induced reinstatement. Repeated SB-334867 treatment (10 or 20 mg/kg) failed to affect reinstatement induced by priming injections of cocaine (10 mg/kg). These results show that repeated inhibition of OX1R-mediated signaling exerts a lasting and specific role in mediating environmentally activated cocaine seeking.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22971541      PMCID: PMC3442258          DOI: 10.1016/j.neuropharm.2012.07.044

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  34 in total

1.  Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior.

Authors:  Benjamin Boutrel; Paul J Kenny; Sheila E Specio; Rémi Martin-Fardon; Athina Markou; George F Koob; Luis de Lecea
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-15       Impact factor: 11.205

2.  Differential effects of the hypocretin 1 receptor antagonist SB 334867 on high-fat food self-administration and reinstatement of food seeking in rats.

Authors:  S G Nair; S A Golden; Y Shaham
Journal:  Br J Pharmacol       Date:  2008-01-28       Impact factor: 8.739

3.  Insular hypocretin transmission regulates nicotine reward.

Authors:  Jonathan A Hollander; Qun Lu; Michael D Cameron; Theodore M Kamenecka; Paul J Kenny
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-24       Impact factor: 11.205

4.  Hypocretins regulate the anxiogenic-like effects of nicotine and induce reinstatement of nicotine-seeking behavior.

Authors:  Ainhoa Plaza-Zabala; Elena Martín-García; Luis de Lecea; Rafael Maldonado; Fernando Berrendero
Journal:  J Neurosci       Date:  2010-02-10       Impact factor: 6.167

5.  Orexin/hypocretin is necessary for context-driven cocaine-seeking.

Authors:  Rachel J Smith; Pouya Tahsili-Fahadan; Gary Aston-Jones
Journal:  Neuropharmacology       Date:  2009-07-08       Impact factor: 5.250

6.  Stimuli linked to ethanol availability activate hypothalamic CART and orexin neurons in a reinstatement model of relapse.

Authors:  Christopher V Dayas; Tresa M McGranahan; Rémi Martin-Fardon; Friedbert Weiss
Journal:  Biol Psychiatry       Date:  2007-06-13       Impact factor: 13.382

7.  Orexin/hypocretin signaling at the orexin 1 receptor regulates cue-elicited cocaine-seeking.

Authors:  Rachel J Smith; Ronald E See; Gary Aston-Jones
Journal:  Eur J Neurosci       Date:  2009-07-28       Impact factor: 3.386

8.  Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine.

Authors:  Stephanie L Borgland; Sharif A Taha; Federica Sarti; Howard L Fields; Antonello Bonci
Journal:  Neuron       Date:  2006-02-16       Impact factor: 17.173

9.  Orexin A/hypocretin-1 selectively promotes motivation for positive reinforcers.

Authors:  Stephanie L Borgland; Shao-Ju Chang; M Scott Bowers; Jennifer L Thompson; Nicole Vittoz; Stan B Floresco; Jonathan Chou; Billy T Chen; Antonello Bonci
Journal:  J Neurosci       Date:  2009-09-09       Impact factor: 6.167

10.  Reinstatement of cocaine seeking by hypocretin (orexin) in the ventral tegmental area: independence from the local corticotropin-releasing factor network.

Authors:  Bin Wang; Zhi-Bing You; Roy A Wise
Journal:  Biol Psychiatry       Date:  2009-02-28       Impact factor: 13.382

View more
  9 in total

1.  Structure-based development of a subtype-selective orexin 1 receptor antagonist.

Authors:  Jan Hellmann; Matthäus Drabek; Jie Yin; Jakub Gunera; Theresa Pröll; Frank Kraus; Christopher J Langmead; Harald Hübner; Dorothee Weikert; Peter Kolb; Daniel M Rosenbaum; Peter Gmeiner
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-15       Impact factor: 11.205

Review 2.  Orexin/hypocretin based pharmacotherapies for the treatment of addiction: DORA or SORA?

Authors:  Shaun Yon-Seng Khoo; Robyn Mary Brown
Journal:  CNS Drugs       Date:  2014-08       Impact factor: 5.749

3.  Orexin-A/Hypocretin-1 Mediates Cocaine-Seeking Behavior in the Posterior Paraventricular Nucleus of the Thalamus via Orexin/Hypocretin Receptor-2.

Authors:  Alessandra Matzeu; Tony M Kerr; Friedbert Weiss; Rémi Martin-Fardon
Journal:  J Pharmacol Exp Ther       Date:  2016-08-18       Impact factor: 4.030

4.  Orexin/hypocretin receptor 1 signaling mediates Pavlovian cue-food conditioning and extinction.

Authors:  Sara E Keefer; Sindy Cole; Gorica D Petrovich
Journal:  Physiol Behav       Date:  2016-03-02

5.  An investigation of interactions between hypocretin/orexin signaling and glutamate receptor surface expression in the rat nucleus accumbens under basal conditions and after cocaine exposure.

Authors:  Ainhoa Plaza-Zabala; Xuan Li; Mike Milovanovic; Jessica A Loweth; Rafael Maldonado; Fernando Berrendero; Marina E Wolf
Journal:  Neurosci Lett       Date:  2013-10-26       Impact factor: 3.046

6.  Partial MHC/neuroantigen peptide constructs attenuate methamphetamine-seeking and brain chemokine (C-C motif) ligand 2 levels in rats.

Authors:  Jennifer M Loftis; Tommy Navis; Jonathan Taylor; Rebekah Hudson; Ulziibat Person; K Matthew Lattal; Arthur A Vandenbark; Renee Shirley; Marilyn Huckans
Journal:  Eur J Pharmacol       Date:  2020-05-13       Impact factor: 4.432

Review 7.  Orexin antagonists for neuropsychiatric disease: progress and potential pitfalls.

Authors:  Jiann Wei Yeoh; Erin J Campbell; Morgan H James; Brett A Graham; Christopher V Dayas
Journal:  Front Neurosci       Date:  2014-02-25       Impact factor: 4.677

Review 8.  Drug Seeking and Relapse: New Evidence of a Role for Orexin and Dynorphin Co-transmission in the Paraventricular Nucleus of the Thalamus.

Authors:  Alessandra Matzeu; Rémi Martin-Fardon
Journal:  Front Neurol       Date:  2018-08-28       Impact factor: 4.003

Review 9.  Targeting the Orexin System for Prescription Opioid Use Disorder.

Authors:  Alessandra Matzeu; Rémi Martin-Fardon
Journal:  Brain Sci       Date:  2020-04-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.